Rajamani, Karthyayani <br/><br/>
n-Butylidenephthalide exhibits protection against neurotoxicity through regulation of tryptophan 2, 3 dioxygenase in spinocerebellar ataxia type 3.  [electronic resource] 

 -  Neuropharmacology  05 2017 
 - 434-446 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7064 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2017.02.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Ataxin-3--metabolism<br/>Calcium--metabolism<br/>Calpain--metabolism<br/>Cerebellum--drug effects<br/>Disease Models, Animal<br/>HEK293 Cells<br/>Humans<br/>Machado-Joseph Disease--drug therapy<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Motor Activity--drug effects<br/>Neuroprotective Agents--pharmacology<br/>Phthalic Anhydrides--pharmacology<br/>Quinolinic Acid--administration & dosage<br/>Ryanodine Receptor Calcium Release Channel--metabolism<br/>Tryptophan--metabolism<br/>Tryptophan Oxygenase--metabolism